Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085632 (
apathy
)
4,089
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Realistic, everyday rewards contain multiple components. An apple has taste and size. However, we choose in single dimensions, simply preferring some apples to others. How can such single-dimensional preference relationships refer to multicomponent choice options? Here, we measured how stochastic choices revealed preferences for 2-component milkshakes. The preferences were intuitively graphed as
indifference
curves that represented the orderly integration of the 2 components as trade-off: parts of 1 component were given up for obtaining 1 additional unit of the other component without a change in preference. The well-ordered, nonoverlapping curves satisfied leave-one-out tests, followed predictions by machine learning decoders and correlated with single-dimensional Becker-DeGroot-Marschak (BDM) auction-like bids for the 2-component rewards. This accuracy suggests a decision process that integrates multiple reward components into single-dimensional estimates in a systematic fashion. In interspecies comparisons, human performance matched that of highly experienced laboratory monkeys, as measured by accuracy of the critical trade-off between bundle components. These data describe the nature of choices of multicomponent choice options and attest to the validity of the rigorous economic concepts and their convenient graphic schemes for explaining choices of human and nonhuman primates. The results encourage formal behavioral and neural investigations of normal, irrational, and pathological economic choices. (PsycInfo Database Record (c) 2020 APA, all rights
reserved
).
...
PMID:Experimentally revealed stochastic preferences for multicomponent choice options. 3271 55
The
Apathy
Evaluation Scale (AES) is a tool utilized with individuals with brain injury, neurocognitive disorders, and other mixed populations to quantify and characterize
apathy
in adults. The scale "treats
apathy
as a psychological dimension defined by simultaneous deficits in the overt behavioral, cognitive, and emotional concomitants of goal-directed behavior." It has three versions: self-rated (AES-S), clinician-rated (AES-C), and informant-rated (AES-I). Using factor analysis, Marin and colleagues identified three factors for the scale, including general
apathy
, disinterest or amotivation, and lack of concern. The psychometric properties of the AES have been examined in various clinical cohorts, including individuals with Alzheimer's disease (AD), traumatic brain injury (TBI), acquired brain injury, multiple sclerosis, severe mental illness, and cognitively healthy middle-aged cohort who are at risk for AD. The AES is a useful, reliable, and valid instrument to quantify and measure severity of
apathy
symptoms in adults. It is important to note that the AES-C and AES-S were able to discriminate
apathy
from depression and anxiety better than the AES-I did. It has been translated into Japanese, Portuguese, German, and Turkish. As a neuropsychiatric symptom,
apathy
should be measured in examining problems of relevance to psychology, psychiatry, and neurology, which may aid in understanding motivation, prognosis, and differential diagnosis. (PsycInfo Database Record (c) 2020 APA, all rights
reserved
).
...
PMID:Clinical utility and psychometric properties of the Apathy Evaluation Scale. 3280 34
<< Previous
1
2